Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim ...
Regular fecal occult blood test (FOBT) screening for colorectal cancer is cost-effective in the general population, yet data are limited regarding the cost-effectiveness of FOBT screening in renal ...
[19] This study was limited by failure to establish the reliability of the bililabstix as a test for occult blood, failure to blind the test results, and retrospective patient classification.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果